The Serbian Minister of Science, Technological Development and Innovation, Jelena Begovic, and the CEO of the Swiss company Swiss Rockets AG, Vladimir Cmiljanovic, have signed a memorandum of understanding stipulating the Swiss company building a nuclear medicine innovation centre on the premises of the BIO4 campus.
Swiss Rockets AG consists of a network of companies and has a considerable number of innovations in their portfolio and they have decided to take transfer their know-how and technologies to Serbia, the Government’s official website reports.
The minister added that this company will also aid the development of the startup ecosystem in the field of biotechnology in Serbia and that it has already started cooperation with our scientific and research institutes, such as INEP and the Institute of Chemistry, Technology and Metallurgy (IHTM).
“These institutes are the future tenants of the BIO4 campus, and this is the first concrete project with a Swiss company,” the Minister said.
Cmiljanovic pointed out the Swiss company decided to establish cooperation with our country on setting up the so-called theranostic innovation centre.
“These are state-of-the-art hospitals, where we will produce the latest molecules for personalized cancer medicine. We will work with the latest technologies for scanning patients with metastases and then, based on those technologies, we will be able to utilize those molecules in order to successfully treat patients with metastases,” Cmiljanovic explained.
Cmiljanovic also pointed out that those projects are very important for patients with tumours, primarily patients with prostate metastases, neuroendocrine tumours, glioblastomas and breast cancer.
This post is also available in: Italiano